Australian Biotech And Device Companies Want R&D Tax Incentive Extended To Manufacturing: Survey
This article was originally published in PharmAsia News
Executive Summary
Firms want to push the idea of tax incentives to spur R&D downstream to include manufacturing to boost biomedical exports for an industry that built up muscle as a global supplier.